MRK

5 Not-So-Crazy Blue-Chip Spinoffs

Here are some not-so-crazy spinoff ideas we might see in 2014 as some big-name blue chips look to streamline operations and align strategy with structure. More 

8 Pharmaceutical Stocks to Buy Now

The grades of eight pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

Healthcare Stocks: No Longer a Sure Thing

Healthcare stocks have outperformed in recent years, but investors need to be selective with valuations that now are at richer levels. More 

Top 10 Dow Dividend Stocks for January

The market rally is getting more selective as we go deeper into 2014. Stick with these safe dividend stocks that have a history of dependable payouts. More 

MRK: Merck Stock a Strong Performer In the Pharma Space

Merck is one the most high profile companies in the pharmaceutical industry, and Merck stock is well worth a look for investors. I rate it a buy today. More 

The S&P’s Most Dramatic Performances of 2013 (And What They Taught Us)

We look at 2013's best and worst performers in the S&P 500, as well as what that might say about returns in 2014. More 

5 (New) Buys, and 5 ‘Deletions’ to the 2014 Stock Buy List

Last week I gave you my 2014 Stock Buy List; this week find out why I've chosen my 5 new "buys", and the 5 "deletions" for the list... More